Arthritis Research & Therapy (Jan 2024)

Specific-cytokine associations with outcomes in knee osteoarthritis subgroups: breaking down disease heterogeneity with phenotyping

  • Joan Calvet,
  • Antoni Berenguer-Llergo,
  • Cristóbal Orellana,
  • María García-Manrique,
  • Menna Rusiñol,
  • Silvia Garcia-Cirera,
  • Maria Llop,
  • Marta Arévalo,
  • Alba Garcia-Pinilla,
  • Carlos Galisteo,
  • Cristina Aymerich,
  • Rafael Gómez,
  • Alejandra Serrano,
  • Anna Carreras,
  • Jordi Gratacós

DOI
https://doi.org/10.1186/s13075-023-03244-y
Journal volume & issue
Vol. 26, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Background Despite existing extensive literature, a comprehensive and clinically relevant classification system for osteoarthritis (OA) has yet to be established. In this study, we aimed to further characterize four knee OA (KOA) inflammatory phenotypes (KOIP) recently proposed by our group, by identifying the inflammatory factors associated with KOA severity and progression in a phenotype-specific manner. Methods We performed an analysis within each of the previously defined four KOIP groups, to assess the association between KOA severity and progression and a panel of 13 cytokines evaluated in the plasma and synovial fluid of our cohort’s patients. The cohort included 168 symptomatic female KOA patients with persistent joint effusion. Results Overall, our analyses showed that associations with KOA outcomes were of higher magnitude within the KOIP groups than for the overall patient series (all p-values < 1.30e−16) and that several of the cytokines showed a KOIP-specific behaviour regarding their associations with KOA outcomes. Conclusion Our study adds further evidence supporting KOA as a multifaceted syndrome composed of multiple phenotypes with differing pathophysiological pathways, providing an explanation for inconsistencies between previous studies focussed on the role of cytokines in OA and the lack of translational results to date. Our findings also highlight the potential clinical benefits of accurately phenotyping KOA patients, including improved patient stratification, tailored therapies, and the discovery of novel treatments.

Keywords